Drug-induced Hypertension: An Unappreciated Cause of Secondary Hypertension

被引:108
作者
Grossman, Ehud [1 ,2 ,3 ]
Messerli, Franz H. [4 ,5 ]
机构
[1] Chaim Sheba Med Ctr, Dept Internal Med D, IL-52621 Tel Hashomer, Israel
[2] Chaim Sheba Med Ctr, Hypertens Unit, IL-52621 Tel Hashomer, Israel
[3] Tel Aviv Univ, Sackler Sch Med, Dept Med, IL-69978 Tel Aviv, Israel
[4] St Lukes Roosevelt Hosp, Div Cardiol, New York, NY 10025 USA
[5] Columbia Univ Coll Phys & Surg, New York, NY 10032 USA
关键词
Hypertension; HIGH BLOOD-PRESSURE; ANGIOGENESIS INHIBITOR; CYCLOOXYGENASE-2; INHIBITORS; ARTERIAL-HYPERTENSION; ALCOHOL-CONSUMPTION; ANALGESIC USE; CYCLOSPORINE; RISK; BEVACIZUMAB; THERAPY;
D O I
10.1016/j.amjmed.2011.05.024
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A myriad variety of therapeutic agents or chemical substances can induce either a transient or persistent increase in blood pressure, or interfere with the blood pressure-lowering effects of antihypertensive drugs. Some agents cause either sodium retention or extracellular volume expansion, or activate directly or indirectly the sympathetic nervous system. Other substances act directly on arteriolar smooth muscle or do not have a defined mechanism of action. Some medications that usually lower blood pressure may paradoxically increase blood pressure, or an increase in pressure may be encountered after their discontinuation. In general, drug-induced pressure increases are small and transient: however, severe hypertension involving encephalopathy, stroke, and irreversible renal failure have been reported. The deleterious effect of therapeutic agents is more pronounced in patients with preexisting hypertension, in those with renal failure, and in the elderly. Careful evaluation of a patient's drug regimen may identify chemically induced hypertension and obviate unnecessary evaluation and facilitate antihypertensive therapy. Once chemical-induced hypertension has been identified, discontinuation of the causative agent is recommended, although hypertension can often be managed by specific therapy and dose adjustment if continued use of the offending agent is mandatory. The present review summarizes the therapeutic agents or chemical substances that elevate blood pressure and their mechanisms of action. (C) 2012 Elsevier Inc. All rights reserved. . The American Journal of Medicine (2012) 125, 14-22
引用
收藏
页码:14 / 22
页数:9
相关论文
共 75 条
[1]   Effects of hormonal replacement therapy in postmenopausal hypertensive patients [J].
Affinito, P ;
Palomba, S ;
Bonifacio, M ;
Fontana, D ;
Izzo, R ;
Trimarco, B ;
Nappi, C .
MATURITAS, 2001, 40 (01) :75-83
[2]   The impact of nonsteroidal anti-inflammatory drugs on blood pressure, with an emphasis on newer agents [J].
Armstrong, EP ;
Malone, DC .
CLINICAL THERAPEUTICS, 2003, 25 (01) :1-18
[3]   Meta-analysis of cyclooxygenase-2 inhibitors and their effects on blood pressure [J].
Aw, TJ ;
Haas, SJ ;
Liew, D ;
Krum, H .
ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (05) :490-496
[4]  
Awang Dennis V C, 2002, J Cardiovasc Nurs, V16, P64
[5]   Hypertension in an urban HIV-positive population compared with the general population: influence of combination antiretroviral therapy [J].
Baekken, Morten ;
Os, Ingrid ;
Sandvik, Leiv ;
Oektedalen, Olav .
JOURNAL OF HYPERTENSION, 2008, 26 (11) :2126-2133
[6]  
Bangalore S, 2007, J AM COLL CARDIOL, V49, P528, DOI 10.1016/j.jacc.2006.10.044
[7]   Paracetamol: New vistas of an old drug [J].
Bertolini, Alfio ;
Ferrari, Anna ;
Ottani, Alessandra ;
Guerzoni, Simona ;
Tacchi, Raffaella ;
Leone, Sheila .
CNS DRUG REVIEWS, 2006, 12 (3-4) :250-275
[8]   Hypertension and clinical benefit of bevacizumab in the treatment of advanced renal cell carcinoma [J].
Bono, P. ;
Elfving, H. ;
Utriainen, T. ;
Osterlund, P. ;
Saarto, T. ;
Alanko, T. ;
Joensuu, H. .
ANNALS OF ONCOLOGY, 2009, 20 (02) :393-394
[9]   Severe hypertension and renal atrophy associated with indinavir [J].
Cattelan, AM ;
Trevenzoli, M ;
Naso, A ;
Meneghetti, F ;
Cadrobbi, P .
CLINICAL INFECTIOUS DISEASES, 2000, 30 (03) :619-621
[10]   Do COX-2 inhibitors raise blood pressure more than nonselective NSAIDs and placebo? An updated meta-analysis [J].
Chan, Clara C. ;
Reid, Christopher M. ;
Aw, Tai-Juan ;
Liew, Danny ;
Haas, Steven Joseph ;
Krum, Henry .
JOURNAL OF HYPERTENSION, 2009, 27 (12) :2332-2341